These final results, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the strategy of focusing on ACKR3 as a unique technique to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Diseases. Will help to https://josephl354biv2.bloggactivo.com/profile